Taylor Boyd joined Raymond James in 2020 as a vice president focusing on biotechnology. Mr. Boyd has more than eight years of experience in advising clients on capital markets and strategic advisory transactions, primarily focused on biopharmaceutical clients. Mr. Boyd previously worked for SVB Leerink, where he was a Vice President. Previously, Mr. Boyd was an Associate at both Cantor Fitzgerald and RBC Capital Markets in their health care investment banking groups. Mr. Boyd began his career at Grant Thornton where he assisted both strategic and sponsor acquirers with buy and sell side financial due diligence. Mr. Boyd holds a Master of Science in accountancy from Wake Forest University and a Bachelor of Science in accounting from North Carolina State University.